Envoy Medical
COCH
22 hedge funds and large institutions have $3M invested in Envoy Medical in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 2 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
2% more capital invested
Capital invested by funds: $2.95M → $3M (+$52.7K)
0.87% more ownership
Funds ownership: 9.95% → 10.82% (+0.87%)
8% less funds holding
Funds holding: 24 → 22 (-2)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACP
Arcus Capital Partners
Atlanta,
Georgia
|
+$275K |
| 2 |
Focus Partners Wealth
Boston,
Massachusetts
|
+$170K |
| 3 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
+$50.9K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$25.3K |
| 5 |
Morgan Stanley
New York
|
+$14.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$41.6K |
| 2 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$12.7K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |
| 4 |
BlackRock
New York
|
-$413 |
| 5 |
SS
SBI Securities
Tokyo,
Japan
|
-$14 |
COCH Hedge Fund Activity: Q1 2025 in Review
22 of the 7,476 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q1 2025, worth a combined $3M — up 1.8% from $2.95M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of COCH and 1 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 6 added.
The largest buyer was Arcus Capital Partners, opening a new position worth an estimated $275K. The largest seller was Citadel Advisors, exiting entirely with an estimated $41.6K sold.
- 22 institutional investors held Envoy Medical (COCH) as of Q1 2025, down from 24 in Q4 2024.
- Funds reported $3M of Envoy Medical stock for Q1 2025, up 1.8% quarter-over-quarter.
- 1 fund opened new Envoy Medical positions in Q1 2025 and 2 closed out, a net change of -1 holder.
- The largest Envoy Medical buyer in Q1 2025 was Arcus Capital Partners, an estimated $275K added.
- The largest Envoy Medical seller in Q1 2025 was Citadel Advisors, an estimated $41.6K sold.
Based on aggregated 13F filings for Q1 2025.